La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Titre (en) » - entrée « dopamine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
dopa < dopamine < dopaminergic  Facettes :

List of bibliographic references indexed by dopamine

Number of relevant bibliographic references: 356.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
000709 (2015) Emily M. Rocha [États-Unis] ; Gaynor A. Smith [États-Unis] ; Eric Park [États-Unis] ; Hongmei Cao [États-Unis] ; Eilish Brown [États-Unis] ; Melissa A. Hayes [États-Unis] ; Jonathan Beagan [États-Unis] ; Jesse R. Mclean [États-Unis] ; Sarah C. Izen [États-Unis] ; Eduardo Perez-Torres [États-Unis] ; Penelope J. Hallett [États-Unis] ; Ole Isacson [États-Unis]Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons.
000734 (2015) Anne Almey [Canada] ; Teresa A. Milner [États-Unis] ; Wayne G. Brake [Canada]Estrogen receptors in the central nervous system and their implication for dopamine-dependent cognition in females
000739 (2015) Consiglia Pacelli [Canada] ; Nicolas Giguère [Canada] ; Marie-Josée Bourque [Canada] ; Martin Lévesque [Canada] ; Ruth S. Slack [Canada] ; Louis-Éric Trudeau [Canada]Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons.
000751 (2015) Fang Ba [Canada] ; W R Wayne Martin [Canada]Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice.
000752 (2015) Paolo Solla [Italie] ; Alfonso Fasano [Canada] ; Antonino Cannas [Italie] ; Cesare Salvatore Mulas [Italie] ; Maria Giovanna Marrosu [Italie] ; Anthony E. Lang [Canada] ; Francesco Marrosu [Italie]Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion.
000753 (2015) Lei Xing ; Heather Mcdonald ; Dillon F. Da Fonte ; Juan M. Gutierrez-Villagomez ; Vance L. TrudeauDopamine D1 receptor activation regulates the expression of the estrogen synthesis gene aromatase B in radial glial cells
000782 (2015) Stéphanie De Gois [France, Canada] ; Patrick Slama [France] ; Nicolas Pietrancosta [France] ; Amaia M. Erdozain [France] ; Franck Louis [France] ; Caroline Bouvrais-Veret [France] ; Laurent Daviet [France] ; Bruno Giros [France, Canada]Ctr9, a Protein in the Transcription Complex Paf1, Regulates Dopamine Transporter Activity at the Plasma Membrane*
000798 (2015) Mattia Volta [Canada] ; Stefano Cataldi [Canada] ; Dayne Beccano-Kelly [Canada] ; Lise Munsie [Canada] ; Igor Tatarnikov [Canada] ; Patrick Chou [Canada] ; Sabrina Bergeron [Canada] ; Emma Mitchell [Canada] ; Roscoe Lim [Canada] ; Jaskaran Khinda [Canada] ; Alejandro Lloret [États-Unis] ; C Frank Bennett [États-Unis] ; Carmela Paradiso [Italie] ; Michele Morari [Italie] ; Matthew J. Farrer [Canada] ; Austen J. Milnerwood [Canada]Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine release.
000827 (2015) María Sierra [Espagne] ; Sébastien Carnicella [France] ; Antonio P. Strafella [Canada] ; Amélie Bichon [France] ; Eugénie Lhommée [France] ; Anna Castrioto [France] ; Stephan Chabardes [France] ; Stéphane Thobois [France] ; Paul Krack [France]Apathy and Impulse Control Disorders: Yin & Yang of Dopamine Dependent Behaviors.
000851 (2015) Beryl Luk [Canada] ; Mohinuddin Mohammed [Canada] ; Fang Liu [Canada] ; Frank J. S. Lee [Canada]A Physical Interaction between the Dopamine Transporter and DJ-1 Facilitates Increased Dopamine Reuptake
000875 (2014) Gonzalo Sanchez [Canada] ; Rafael K. Varaschin [Canada] ; Hansruedi Büeler [République populaire de Chine] ; Paul C. Marcogliese [Canada] ; David S. Park [Canada] ; Louis-Eric Trudeau [Canada]Unaltered Striatal Dopamine Release Levels in Young Parkin Knockout, Pink1 Knockout, DJ-1 Knockout and LRRK2 R1441G Transgenic Mice
000877 (2014) Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Katie D. Lewis [Australie] ; James B. Koprich [Canada] ; M Gabriela Reyes [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Jonathan M. Brotchie [Canada]UWA-121, a mixed dopamine and serotonin re-uptake inhibitor, enhances L-DOPA anti-parkinsonian action without worsening dyskinesia or psychosis-like behaviours in the MPTP-lesioned common marmoset.
000892 (2014) Crystal A. Clark ; Alain DagherThe role of dopamine in risk taking: a specific look at Parkinson’s disease and gambling
000909 (2014) Carlos Cepeda [États-Unis] ; Kerry P. S. Murphy [Royaume-Uni] ; Martin Parent [Canada] ; Michael S. Levine [États-Unis]The Role of Dopamine in Huntington’s Disease
000920 (2014) Vincent A. Jourdain [Canada] ; Nicolas Morin [Canada] ; Marc Morissette [Canada] ; Laurent Grégoire [Canada] ; Thérèse Di Paolo [Canada]Subthalamotomy-induced changes in dopamine receptors in parkinsonian monkeys.
000934 (2014) Julio Cesar Aguila [États-Unis] ; Alexandra Blak [États-Unis] ; Joris Van Arensbergen [États-Unis] ; Amaia Sousa [États-Unis] ; Nerea Vázquez [États-Unis] ; Ariane Aduriz [États-Unis] ; Mayela Gayosso [États-Unis] ; Maria Paz Lopez Mato [États-Unis] ; Rakel Lopez De Maturana [États-Unis] ; Eva Hedlund [États-Unis] ; Kai-Christian Sonntag [États-Unis] ; Rosario Sanchez-PernauteSelection Based on FOXA2 Expression Is Not Sufficient to Enrich for Dopamine Neurons From Human Pluripotent Stem Cells.
000936 (2014) Leigh Christopher [Canada] ; Sarah Duff-Canning [Canada] ; Yuko Koshimori [Canada] ; Barbara Segura [Canada, Espagne] ; Isabelle Boileau [Canada] ; Robert Chen [Canada] ; Anthony E. Lang [Canada] ; Sylvain Houle [Canada] ; Pablo Rusjan [Canada] ; Antonio P. Strafella [Canada]Salience Network and Parahippocampal Dopamine Dysfunction in Memory-Impaired Parkinson Disease
000941 (2014) Thomas J. Moore [États-Unis] ; Joseph Glenmullen [États-Unis] ; Donald R. Mattison [Canada]Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs.
000981 (2014) Craig J. Hudson [Canada] ; Philip Seeman [Canada] ; Mary V. Seeman [Canada]Parkinson's Disease: Low-Dose Haloperidol Increases Dopamine Receptor Sensitivity and Clinical Response
000990 (2014) Kristian Thorlund [Canada, États-Unis] ; Ping Wu [Canada] ; Eric Druyts [Canada] ; Shawn Eapen [Canada] ; Edward J. Mills [États-Unis, Canada]Nonergot dopamine-receptor agonists for treating Parkinson’s disease – a network meta-analysis
000A06 (2014) Antonio Cerasa [Italie] ; Alfonso Fasano [Canada] ; Francesca Morgante [Italie] ; Giacomo Koch [Italie] ; Aldo Quattrone [Italie]Maladaptive Plasticity in Levodopa-Induced Dyskinesias and Tardive Dyskinesias: Old and New Insights on the Effects of Dopamine Receptor Pharmacology

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "dopamine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "dopamine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    dopamine
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022